If you need more lookups,
subscriptions start at $34 USD/month.
Claudio Ullmann Location
Potomac, MD, US
Claudio Ullmann Work
2026 -now Chief Medical Officer @
2021 -now Oncology Drug Development Executive. @ Oncology Therapeutics Clinical Development
2024 -2025 Chief Medical Officer @
2022 -2024 Chief Medical Officer @ Avenge Bio
2018 -2021 Chief Medical Officer @ CARMA Cell Therapies, MaxCyte, Inc.
2016 -2018 Senior Vice President, Head of Clinical Development @
2015 -2016 Vice President, Head of Clinical Development @
2012 -2015 Senior Medical Director, Global Clinical Lead, Clinical Development, Oncology Clinical Research @
2005 -2012 Head, Thoracic and Head and Neck Malignancies, Melanoma and Other Skin Cancers Therapeutics @ Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Canc
Claudio Ullmann Skills
Strategic Planning
Strategic Development
Business Strategy
Clinical Development
Ovarian Cancer
Medicine
Drug Discovery
Drug Development
Pharmaceutical Industry
Microsoft Excel
Lung Cancer
Development
Cancer
Biomarker Development
Biotechnology
Oncology
Translational Research
Medical Oncology
Clinical Trials
Cancer Immunotherapy
Breast Cancer
Strategy
Stem Cell Research
Translational Medicine
Oncology Clinical Research
Medical Affairs
Clinical Research
Melanoma
SQL
Biomarkers
Oncology Clinical
Immunology
Life Sciences
Claudio Ullmann Summary
Claudio Ullmann, based in Potomac, MD, US, is currently a Chief Medical Officer at ImmunoGenesis, Inc.. Claudio Ullmann brings experience from previous roles at Oncology Therapeutics Clinical Development, Context Therapeutics, Avenge Bio and CARMA Cell Therapies, MaxCyte, Inc.. With a robust skill set that includes Strategic Planning, Strategic Development, Business Strategy, Clinical Development, Ovarian Cancer and more. Claudio Ullmann has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Claudio Ullmann?
Find contact details for 700 million professionals.